Pulmonary Embolism

This channel includes news and new technology innovations for Pulmonary Embolism. This condition occurs when an artery in the lungs is blocked, usually caused by a blood clot.

The system treats severe pulmonary regurgitation (PR) in the native or surgically repaired right ventricular outflow tract (RVOT).

News | Structural Heart

Medtronic Harmony Transcatheter Pulmonary Valve Demonstrates Strong 2-year Outcomes

May 24, 2023 — Medtronic announced two-year results of their Harmony Transcatheter Pulmonary Valve (TPV) System, which ...

May 24, 2023

News | Pulmonary Embolism

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

March 10, 2023

Integrated with the Rapid PE solution, Rapid RV/LV further accelerates time to triage and diagnose pulmonary embolism patients with right heart strain

News | Pulmonary Embolism

RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Product

February 22, 2023 — RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and ...

February 22, 2023

Alameda, CA-based global healthcare company Penumbra has announced Food & Drug Administration (FDA) clearance and launch of Lightning Flash, which the company reports is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus.

News | Cardiovascular Business

FDA Clearance and Launch Granted to Penumbra Mechanical Thrombectomy System

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

January 11, 2023

Screen shots of Viz PE with RV/LV ratio data (left), along with the company’s ECG Viewer (right). Both are part of the comprehensive Viz Cardio Suite designed to speed and improve patient access to innovative cardiovascular treatments. Source: Viz.ai.

News | Pulmonary Embolism

Viz.ai Launches AI-Powered Viz Cardio Suite

November 17, 2022 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced the ...

November 17, 2022

Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients

News | Venous Therapies

ABRE Clinical Study 36-Month Data Shows Sustained Effectiveness of Abre Venous Self-Expanding Stent System

October 14, 2022 — Medtronic, a global leader in medical technology, announced the 36-month final results from the ABRE ...

October 14, 2022

Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

News | Stroke

Anthos Therapeutics Announces Abelacimab Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with AFib

September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ...

September 13, 2022

The Pulmonary Hypertension Association (PHA) joins more than 80 organizations around the world on Thursday, May 5, to recognize World PH Day.

News | Heart Failure

World PH Day Raises Awareness for Pulmonary Hypertension’s Global Impact

April 20, 2022 – The Pulmonary Hypertension Association (PHA) joins more than 80 organizations around the world on ...

April 20, 2022

Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus catheter-directed thrombolysis (CDT).

News | Pulmonary Embolism

Inari Medical Announces First Patient Enrolled in the PEERLESS Trial

February 16, 2022 – Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a ...

February 16, 2022

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI) algorithms can detect signs of these clots in electrocardiograms (EKGs), a finding which may one day help doctors with screening.

News | Pulmonary Embolism

Could EKGs Help Doctors Use AI to Detect Pulmonary Embolisms?

February 14, 2022 — Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Ica ...

February 14, 2022

Videos | Artificial Intelligence

VIDEO: Examples of Artificial Intelligence PE Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism (PE) response team apps featured by ...

January 13, 2022

News | Thrombectomy Devices

Akura Medical Closes $25 Million in A1 Financing to Develop New Thrombectomy System

January 10, 2022 – Akura Medical Inc., a Shifamed portfolio company, announced the closing of its $25 million Series A1 ...

January 10, 2022

The Viz.AI pulmonary embolism response team (PERT) app that uses AI to detect PE on images before they go into PACS, alerts the PERT team members and provides a mobile platform to message, review images and other patient data. Photo by Dave Fornell

Feature | Artificial Intelligence | By Dave Fornell, DAIC Editor

AI Can Facilitate Automated Activation of Pulmonary Embolism Response Teams

Artificial intelligence (AI) has found a unique niche to help automate the activation of acute care teams for pulmonary ...

December 09, 2021

Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE).

News | Pulmonary Embolism

Study Compares Interventional Pulmonary Embolism Therapy in Combination With Anticoagulation to Anticoagulation Alone

August 9, 2021 — Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative ...

August 09, 2021

An example of Viz.AI's pulmonary embolism AI application and mobile alert to the physician on-call. Viz.AI and Avicenna.AI Partner to Launch Artificial Intelligence Care Coordination for Pulmonary Embolism and Aortic Disease

News | Artificial Intelligence

Viz.AI and Avicenna.AI Partner to Launch Artificial Intelligence Care Coordination for Pulmonary Embolism and Aortic Disease

July 21, 2021 — Artificial intelligence (AI) medical imaging vendors Viz.AI and Avicenna.AI have partnered to enable ...

July 21, 2021